Our supporters

Alturix are a dynamic pharmaceutical company who are committed to building and nurturing meaningful partnerships with our customers in the UK. We are dedicated to delivering a growing portfolio of high quality products to help improve patient outcomes, at responsible prices. This is in accordance with our values of Integrity, Partnership and Reliability.

Visit website

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of products. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Visit website

UKI-00-220040, August 2022

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company develops innovative technology, services and solutions that help advance clinical therapy for patients and clinical process for health care providers. With presence in virtually every country around the world, BD helps customers enhance outcomes, lower costs, increase efficiencies, and improve patient safety and access to health care.

Visit website

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations for people living with serious neurological diseases as well as related therapeutic adjacencies.  Biogen has a portfolio of medicines and potential therapies across neurology, neuropsychiatry, specialised immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

To learn more, please visit www.biogen.uk.com, www.biogen.ie.

June 2023 Biogen: 141598

Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine.Within our areas of specialisation, we start from pre-clinical and clinical development to manufacturing and global marketing. Research, development and production are carried out at our main headquarters in Dreieich, Germany. Biotest (UK) Ltd. based in Longbridge, Birmingham has operated in the UK for more than 50 years.

Visit Biotest website

B. Braun is one of the world’s leading medical technology companies. With over 66,000 employees, the family-owned company is a true partner, developing smart solutions and setting standards to drive advancements in health care.

Visit website

Count on us to keep them in the moment.

At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology. Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs.

For more information visit https://www.daiichi-sankyo.co.uk

Dr Falk Pharma drives innovation in digestive and metabolic medicine, developing therapies that work for people, not just diseases.

We’ve always believed in the power of collaboration and facilitate educational events along with supporting patient societies promoting shared learning between patients, clinicians and researchers.

Tap into FalkPlus now and be a part of our future – download on https://install.events/falkplus on your desktop and mobile devices and register for the Dr Falk educational events.

Visit www.drfalk.co.uk to access the Dr Falk resources.

Active in the anti-infective area for more than 35 years, we at Eumedica ensure the continuity of access to quality & lifesaving therapeutic solutions for healthcare practitioners and patients. We focus on maintaining a diversified range of specific and niche therapeutical solutions that covers critical unmet medical needs. With one of our specialties defined as “essential medicine” by the WHO, our products are exclusively manufactured in Europe.

Visit website

Lilly unites caring with discovery to create medicines that make life better for people. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Our scientists are urgently advancing new discoveries to address some of the world’s most significant health challenges, in diabetes care, obesity, Alzheimer’s disease, immunology and oncology. We’re motivated by one thing: making life better for millions more people. To learn more, visit www.lilly.co.uk

We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us.

Medtronic. Engineering the extraordinary.

Visit website

Orion Pharma (UK) Ltd is a subsidiary of Orion Corporation, pharmaceutical company based in Finland. Orion carries out extensive research with a goal of introducing new treatments into global markets. The core therapy areas of Orion are neurological disorders, oncology and respiratory disease.

Visit website

August 2022/CORP-233(1)

Pharmacosmos are specialists in iron therapy. Globally we develop, manufacture and market medicines for iron deficiency in humans and animals.

In the UK and Ireland, Pharmacosmos focuses on treatment of iron deficiency in humans, supporting patients and healthcare professionals with a range of iron therapies, tools and resources.

Visit website

Rosemont are specialist manufacturers of oral liquid medicines, with over 50 years dedicated experience. We have an extensive portfolio of products across a range of therapeutic categories. New products are continually being developed at our state-of-the-art UK facilities, to further support patients with swallowing difficulties, and the healthcare professionals who care for them.

Visit website

At Shionogi Europe we believe in doing things differently. We combine our Japanese roots with entrepreneurial European operations to unleash the power of our scientific expertise, making it relevant to healthcare today.

This has enabled us to make life-changing contributions to public health in areas like HIV and AMR. Infectious diseases are our major focus but we also strive to make a difference in areas where unmet clinical need is greatest – such as CNS disorders and rare/ orphan diseases.

Visit website

Takeda Pharmaceutical Company Limited is headquartered in Japan and is a global, values-based, R&D-driven biopharmaceutical leader. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. Our employees are committed to improving quality of life for patients.

www.takeda.com/en-gb

Tillotts have over 30 years’ expertise in developing and manufacturing treatments for inflammatory bowel disease (IBD). We understand the diseases, treatment options and the challenges GI healthcare professionals and patients face.

Tillotts Pharma UK is a market leader in GI health products and provides support in IBD and Clostridioides difficile infections.

Tillotts are passionate about improving patient care and supporting healthcare professionals, with Tillotts education programmes offering in-person and online training and support.

Tillotts are part of the Zeria Group.

Visit website

VIATRIS is a different kind of healthcare company, with a mission to empower people to live healthier at every stage of life, regardless of geography or circumstance.

We believe in healthcare not as it is, but how it should be and are passionately committed to working in partnership to improve and transform UK healthcare, seeking to improve access regardless of geography or circumstance.

Visit website

CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease. CSL Vifor strives to help patients around the world with severe and chronic diseases lead better, healthier lives.

Job number: UK-NP-2300052. Date of prep: July 2023.

Visit website